1-3 of 3
Florence Bellanger
Close
Sort by
Journal Articles

Study of V617F JAK2-Positive and JAK2-Negative Patients within 18 Families with Myeloproliferative Disorders (MPD): Disease Characteristics and Evolution, EPOR and MPL Analysis.

Christine Bellanne-Chantelot, PharmD,PhD, Myriam Labopin, M.D., Florence Bellanger, Isabelle Chaumarel, Françoise Isnard, M.D., Nicole Casadevall, M.D., William Vainchenker, M.D.,Ph.D., Gilles Thomas, M.D.,Ph.D., Albert Najman, M.D., the French Group on Familial MPD
Journal: Blood
Blood (2006) 108 (11): 672.
https://doi.org/10.1182/blood.V108.11.672.672
Published: 2006
Journal Articles

Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders

Clinical Trials & Observations
Christine Bellanné-Chantelot, Isabelle Chaumarel, Myriam Labopin, Florence Bellanger, Véronique Barbu, Claudia De Toma, François Delhommeau, Nicole Casadevall, William Vainchenker, Gilles Thomas, Albert Najman
Journal: Blood
Blood (2006) 108 (1): 346–352.
https://doi.org/10.1182/blood-2005-12-4852
Published: 2006
Journal Articles

Heterogeneous Distribution of the JAK2 Val617Phe Activating Mutation in Familial Myeloproliferative Disorders.

Christine Bellanne-Chantelot, PharmD, PhD, Myriam Labopin, MD, Isabelle Chaumarel, MD, Francois Delhommeau, MD, Gwendoline Leroy, Florence Bellanger, Gilles Thomas, MD, PhD, William Vainchenker, MD, PhD, Albert Najman
Journal: Blood
Blood (2005) 106 (11): 115.
https://doi.org/10.1182/blood.V106.11.115.115
Published: 2005